Effect of Several Herbs on Acetylcholinesterase Enzyme Activity

數 種 韓藥의 아세틸콜린에스터레이즈 酵素活性에 대한 효과

Choi Jae-Hwan;Kim Mi-Young;Kim Hyun-Mi;Cui Xun;Jeon Hoon;Kim Dae-Keun;Lim Jong-Pil;Leem, Kang-Hyun
최재환;김미영;김현미;최훈;전훈;김대근;임종필;임강현

  • Published : 20020000

Abstract

아세틸콜린에스터레이즈(AChE)는 신경조직에 분포하는 효소로 신경전달물질 중 아세틸콜린(ACh)을 분해하는 효소로 시냅스 신호전달체계에 있어 중요한 역할을 하는 효소이다. 현재 알츠하이머병과 치매치료에 사용하는 서양약물은 AChE의 활성을 저해하는 작용기전을 가진다. 목적 : 전통적으로 기억력 감퇴, 치매 등 치료에 사용되어 온 한약의 AChE에 대한 작용을 밝히기 위해 본 실험이 구상되었다. 방법 : 생쥐 대뇌신경세포의 균질 혼합액으로부터 효소의 활성을 Ellman 방법을 개선한 엘리자(ELISA)법을 이용하여 측정하였다. 결과 : 실험결과 天花粉 의 6종이 2.5mg/ml의 농도에서 우수한 효소활성저해력을 보였고, 50% 효소활성 저해농도(ID_50)를 구한 결과, 天花粉의 $ID_50$은 1.5mg/ml이었고, 赤芍藥 1.2 mg/ml, 玄蔘 2.0 mg/ml, 魚腥草 1.2 mg/ml, 忍冬藤 1.0 mg/ml, 桑寄生 1.7mg/ml, 및 大服皮 2.0 mg/ml를 나타내어 忍冬藤의 저해력이 가장 우수하였다. 결론 : 치매 및 기억력감퇴 증상을 치료하는 한약의 작용기전 중 AChE 효소활성억제효과는 忍冬藤 의 6종에서 나타났으며, 이는 전통적인 한방치료에 과학적인 기초자료를 제공할 것으로 생각한다.

Keywords

References

  1. Lancet v.2 no.8000 Selective loss of central cholinergic neurons in Alzheimer's disease Davies P;Maloney AJ
  2. Lancet v.1 no.8004 Necropsy evidence of central cholinergic deficits in senile dementia Perry EK;Perry RH;Blessed G;Tomlinson BE
  3. J Neurol Sci. v.57 no.2-3 Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients Bowen DM;Benton JS;Spillane JA;Smith CC;Allen SJ
  4. Science v.217 no.4558 The cholinergic hypothesis of geriatric memory dysfunction Bartus RT;Dean RL 3rd;Beer B;Lippa AS
  5. Arch Neurol v.36 no.8 Effect of physostigmine on constructional and memory tasks in Alzheimer's disease Muramoto O;Sugishita M;Sugita H;Toyokura Y
  6. Mol Pharmacol v.57 no.2 Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease Camps P;Cusack B;Mallender WD;El Achab RE;Morral J;Munoz-Torrero D;Rosenberry TL
  7. Kor. J. Pharmacogn v.28 no.4 Screening of the acetylcholinesterase inhibitors from medical plants Lee BH;Choi BW;Ryu GS;Lee ES;Kang KJ;Hwang DY;Hong ND
  8. Dev Boil. v.76 no.1 The effects of nerve growth factor on acetylcholinesterase and its multiple forms in cultures of rat PC12 pheochromocytoma cells: increased total specific activity and appearance of the 16 S molecular form Rieger F;Shelanski ML;Greene LA
  9. Biochem Pharmacol v.7 A new and rapid colorimetric determination of acetylcholinesterase activity Ellman GL;Courtney KD;Valentino A;Feather-stone RM
  10. J Biochem Toxicol v.11 no.6 Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos Mortensen SR;Chanda SM;Hooper MJ;Padilla S
  11. Mol Cells v.11 no.2 Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase Chung YK;Heo HJ;Kim EK;Kim HK;Huh TL;Lim Y;Kim SK;Shin DH
  12. Lancet v.2 no.8000 Selective loss of central cholinergic neurons in Alzheimer's disease Davies P;Maloney AJ
  13. Lancet v.1 no.8004 Necropsy evidence of central cholinergic deficits in senile dementia Perry EK;Perry RH;Blessed G;Tomlinson BE
  14. J Neurol Sci. v.57 no.2-3 Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients Bowen DM;Benton JS;Spillane JA;Smith CC;Allen SJ
  15. Science v.217 no.4558 The cholinergic hypothesis of geriatric memory dysfunction Bartus RT;Dean RL 3rd;Beer B;Lippa AS
  16. Arch Neurol. v.36 no.8 Effect of physostigmine on constructional and memory tasks in Alzheimer's disease Muramoto O;Sugishita M;Sugita H;Toyokura Y
  17. Mol Pharmacol. v.57 no.2 Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease Camps P;Cusack B;Mallender WD;El Achab RE;Morral J;Munoz-Torrero D;Rosenberry TL
  18. Kor. J. Pharmacogn. v.28 no.4 Screening of the acetylcholinesterase inhibitors from medical plants Lee BH;Choi BW;Ryu GS;Lee ES;Kang KJ;Hwang DY;Hong ND
  19. Dev Boil. v.76 no.1 The effects of nerve growth factor on acetylcholinesterase and its multiple forms in cultures of rat PC12 pheochromocytoma cells: increased total specific activity and appearance of the 16S molecular form Rieger F;Shelanski ML;Greene LA
  20. Biochem Pharmacol. v.7 A new and rapid colorimetric determination of acetylcholinesterase activity Ellman GL;Courtney D;Valentino A;Featherstone RM
  21. J Biochem Toxicol. v.11 no.6 Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos Mortensen SR;Chanda SM;Hooper MJ;Padilla S
  22. Mol Cells v.11 no.2 Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase Chung YK;Heo HJ;Kim EK;Kim HK;Huh TL;Lim Y;Kim SK;Shin DH